Trial Profile
A retrospective study investigating safety of non-vitamin K oral anticoagulants- Apixaban, Dabigatran-etexilate and Rivaroxaban in Japanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Thrombosis
- Focus Adverse reactions
- 27 Feb 2017 New trial record